Nextel Medical Corp. (MAJI)
OTCMKTS · Delayed Price · Currency is USD
0.0080
+0.0005 (6.67%)
At close: Jun 8, 2026
Nextel Medical Company Description
Nextel Medical Corp., a clinical stage biotechnology company, develops ways to exploit the therapeutic potential of exosomes for the field of oncology in the United States.
The company was formerly known as Exousia Pro, Inc. and changed its name to Nextel Medical Corp. in April 2026.
Nextel Medical Corp. was incorporated in 2010 and is based in Saint Petersburg, Florida.
Nextel Medical Corp.
| Country | United States |
| Founded | 2010 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 3 |
| CEO | Donald Steinberg |
Contact Details
Address: 7901 4th Street N #23494 Saint Petersburg, Florida 33702 United States | |
| Phone | 509 605 6533 |
| Website | exousiapro.com |
Stock Details
| Ticker Symbol | MAJI |
| Exchange | OTCMKTS |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| ISIN Number | US36257K2087 |
| SIC Code | 9995 |
Key Executives
| Name | Position |
|---|---|
| Donald J. Steinberg | Chief Executive Officer and Director |